Description
This report presents an in depth analysis of DNA Sequencing market. The study emphasizes on both, the Methods and Instruments/Software of DNA Sequencing in Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics application areas. Automated and Non-Automated (Sanger’s, Maxam-Gilbert and Pyrosequencing) DNA Sequencing Methods are analyzed. The major Instruments/Software segments encompass Instruments (DNA Sequencers, DNA Synthesizers, DNA Sequencing Kits, and Microarray Technology) and Bio-Informatics. In depth Application analysis of Medical Research fields such as Proteomics, Pharmacogenomics and Molecular Diagnostics is also covered.
The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more 600 companies that are engaged in DNA Sequencing services, instrumentation, R&D and supply of products and services. Major Contract Research Organizations serving the global DNA Sequencing industry are also covered in the corporate directory section of this report. Estimations and predictions are graphically represented by region, by technology and by product segment. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, Japan and Rest of World. The market is analyzed in Dollars and includes 197 exclusive exhibits.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/905710-dna-sequencing-market-research-report
Highlights
DNA is the carrier of genetic information in living organisms. It is said to be the blue print of an organism coordinating the various cellular activities and development. It regulates growth and metabolism and controls the traits, for example eye color. The order or sequence of the bases constitutes the specific instruction for a trait or activity. For example, the sequence ATCGTT may code for blue eye color and ATCGCT may express into brown eye color. But complex traits like intelligence appear to be influenced partly by inheritance and partly by environmental condition. The introduction of DNA sequencing has extensively accelerated the pace of biological research and various discoveries. The quick pace of sequencing can easily be achieved by employing sophisticated modern DNA sequencing technology. This has enabled the large-scale sequencing of the human genome, which is part of the Human Genome Project.
The numerous related projects by scientific collaboration have succeeded in generating the complete DNA sequences of for many plants, animals and microbial genomes across the globe. The success of the human genome project has led to rapid advances in the life science industry. The life science industry in all aspects has received and will carry on receiving a tremendous amount of benefit from the human genome project. The entire range of processes from drug discovery to the progress and introduction of novel therapeutics are expected to contribute to this effect. It is estimated that to develop a drug, an average investment of $1 billion has to be incurred. Out of the drugs that are presented for drug approval only 30% are able to break even. Thus it can be seen that pharmaceutical companies are working against high odds, so the need for streamlining and optimization of the recognition of new therapeutics is an extremely urgent matter. The solution to these problems lies in the profiling of pharmacogenomics. This will help in developing new medicines, which will be efficacious and will be able to achieve the desired result much faster.
This will also augment the diagnostics for the developed drugs, which have already been positioned in the market. With an eye on these potential benefits pharmaceutical and biotechnology companies are keenly looking forward to the use of pharmacogenomics to help them identify compounds that have a profile of good safety and efficacy outlines. Pharmaceutical companies are realizing the importance of drug discovery procedures like DNA sequencing, which reduce time as well as cost of developing a product. In addition, they also verify the effectiveness of a drug. DNA sequencing is showing promising results in treating pathogenic infections such as HIV and Hepatitis virus, as well as other ailments. However, it is gaining prominence because it offers a ray of hope for those afflicted with genetic disorders.
Key Players
454 Life Sciences (USA)
Affymetrix, Inc. (USA)
Agilent Technologies, Inc. (USA)
AgriGen Biotech Pty. Ltd. (Australia)
Avestha Gengraine Technologies Pvt. Ltd. (India)
Beckman Coulter Genomics (USA)
BGI Life Tech Co., Ltd. (China)
Bioneer Corporation (South Korea)
Complete Genomics, Inc. (USA)
DNASTAR, Inc. (USA)
DNAVision SA (Belgium)
Eurofins MWG Operon (Germany)
Evogene Ltd. (Israel)
Fairfax Identity Laboratories (USA)
Fluidigm Corporation (USA)
GATC Biotech AG (Germany)
Gene Logic, Inc. (USA)
Genetic Technologies Limited (Australia)
GeneWorks Pty. Ltd. (Australia)
GVK BIO (India)
Hokkaido System Science Co., Ltd. (Japan)
Hy Laboratories Ltd. (Israel)
Igenbio, Inc. (USA)
Illumina, Inc. (USA)
Inqaba Biotechnical Industries (Pty) Ltd. (South Africa)
Integrated DNA Technologies, Inc. (USA)
Kanehisa Laboratories (Japan)
Microsynth AG (Switzerland)
NetBio, Inc. (USA)
Ocimum Biosolutions Ltd. (India)
Oxford Nanopore Technologies Ltd. (UK)
Pacific Biosciences of California, Inc. (USA)
PrimmBiotech, Inc. (USA)
Promega Corporation (USA)
Qiagen NV (The Netherlands)
RainDance Technologies (USA)
Research Biolabs Pte Ltd. (Singapore)
Roche NimbleGen, Inc. (USA)
Sangon Biotech (Shanghai) Co., Ltd. (China)
Saturn Biotech Limited (Australia)
Sequetech Corporation (USA)
Shimadzu Corporation (Japan)
Sigma-Aldrich Co. LLC (USA)
Thermo Fisher Scientific, Inc. (USA)
Wellcome Trust Sanger Institute (The) (UK)
Leave a Query @ https://www.wiseguyreports.com/enquiry/905710-dna-sequencing-market-research-report
Why buy this Report
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
- Identify Market Opportunities
- Review and Analyze Global and Regional Markets
- Gauge Market Potential for your Products
- Identify Competition
- Use Market Research for exploring new areas
- Acquire Meaningful Guidelines for Strategic Planning
- Gear up for Market Entry
- Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –
- Global and Regional Market Sizes, Market Shares, Market Trends
- Product (Global and Regional) Market Sizes, Market Shares, Market Trends
- Technology Trends
- Corporate Intelligence
- Key Companies By Sales, Brands, Products
- Other Strategic Business Affecting Data
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.